Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to 0.71.

  • Amicus Therapeutics' Asset Utilization Ratio rose 1061.29% to 0.71 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71, marking a year-over-year increase of 1061.29%. This contributed to the annual value of 0.68 for FY2024, which is 2713.5% up from last year.
  • Per Amicus Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.71 for Q3 2025, which was up 1061.29% from 0.71 recorded in Q2 2025.
  • Amicus Therapeutics' 5-year Asset Utilization Ratio high stood at 0.71 for Q2 2025, and its period low was 0.31 during Q1 2021.
  • For the 5-year period, Amicus Therapeutics' Asset Utilization Ratio averaged around 0.5, with its median value being 0.49 (2023).
  • In the last 5 years, Amicus Therapeutics' Asset Utilization Ratio skyrocketed by 995.75% in 2021 and then skyrocketed by 3522.72% in 2022.
  • Amicus Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.33 in 2021, then skyrocketed by 35.23% to 0.44 in 2022, then increased by 16.72% to 0.52 in 2023, then increased by 29.79% to 0.67 in 2024, then increased by 5.76% to 0.71 in 2025.
  • Its Asset Utilization Ratio stands at 0.71 for Q3 2025, versus 0.71 for Q2 2025 and 0.69 for Q1 2025.